Skip to main content
← All Companies
OpenEvidence logo

OpenEvidence

AI Augmented
AI Classification
Existing product enhanced with AI capabilities.

Transforming research into actionable insights

Total Funding

$485M

Founded

2022

Headquarters

San Francisco, United States

Industry Vertical

Health & Biotech

Technology Segments

Clinical Decision SupportAI AgentsData Management

About

OpenEvidence is a leading artificial intelligence platform focused on accelerating clinical decision-making for healthcare professionals. Leveraging large language models and training data sourced from authoritative medical journals, it enables doctors and clinicians to access instant, evidence-based answers within a secure environment. Unlike consumer-focused AI, only verified medical professionals may use the service, ensuring trust and reliability for critical healthcare scenarios.

Funding Rounds

3
DateRoundAmount
2025-10-20Series C$200M
2025-07-15Series B$210M
2025-02-19$75M

Investors

9
Google VenturesSequoia CapitalKleiner PerkinsBlackstoneThrive CapitalCoatue ManagementBondCraft VenturesConviction Capital

Subscribe to Monday AI Signal

Weekly pre-seed and seed AI deal intelligence with early trends.